July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Modelling Sorsby’s Fundus Dystrophy using patient-derived iPSC-RPE
Author Affiliations & Notes
  • Jennifer Dewing
    Clinical Neurosciences, University of Southampton, Southampton, United Kingdom
  • David R. G. Christensen
    Clinical Neurosciences, University of Southampton, Southampton, United Kingdom
  • Heidi Hongisto
    University of Tampere, Finland
  • Jennifer Scott
    Clinical Neurosciences, University of Southampton, Southampton, United Kingdom
  • Ben Jenkins
    Clinical Neurosciences, University of Southampton, Southampton, United Kingdom
  • Angela Jane Cree
    Clinical Neurosciences, University of Southampton, Southampton, United Kingdom
  • Heli Skottman
    University of Tampere, Finland
  • J. Arjuna Ratnayaka
    Clinical Neurosciences, University of Southampton, Southampton, United Kingdom
  • Andrew Lotery
    Clinical Neurosciences, University of Southampton, Southampton, United Kingdom
  • Footnotes
    Commercial Relationships   Jennifer Dewing, None; David Christensen, None; Heidi Hongisto, None; Jennifer Scott, None; Ben Jenkins, None; Angela Cree, None; Heli Skottman, None; J. Arjuna Ratnayaka, None; Andrew Lotery, None
  • Footnotes
    Support  GR590, NC/L001152/1, 24AZ172, Macular Society UK, The Gift of Sight Appeal
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 424. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jennifer Dewing, David R. G. Christensen, Heidi Hongisto, Jennifer Scott, Ben Jenkins, Angela Jane Cree, Heli Skottman, J. Arjuna Ratnayaka, Andrew Lotery; Modelling Sorsby’s Fundus Dystrophy using patient-derived iPSC-RPE. Invest. Ophthalmol. Vis. Sci. 2019;60(9):424.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Sorsby’s fundus dystrophy (SFD) leads to bilateral loss of central vision and is caused by mutations in the gene TIMP3. The mechanisms by which TIMP3 mutations cause SFD are poorly understood. iPSC-retinal pigmented epithelial (RPE) cells were generated from SFD patients and controls (ctrl) and cultured on transwell inserts to develop a RPE cell model which was used to study effects of specific TIMP3 mutations on cellular structure and physiology.

Methods : Human fibroblasts were isolated from SFD (TIMP3 S204C) and ctrl subject skin biopsies by explant migration and reprogrammed into iPSCs. These iPSC colonies were cultured in RPE differentiation medium for 4 weeks until sufficient pigmentation was achieved before being transferred to transwells. Transmission electron microscopy (TEM) was used to analyse morphological differences between SFD and ctrl RPE cells. Transepithelial electrical resistance (TEER) was used to measure RPE barrier integrity. To assess the ability of TIMP3 to inhibit MMP activity, protein lysates from SFD and ctrl RPE cells were tested in an EnzCheck collagenase assay.

Results : iPSC-RPE cells were successfully derived from SFD and ctrl patients. TEM analysis revealed significant differences in RPE containing mutant TIMP3 with respect to cell height (SFD 10.3µm ±0.23 SEM, ctrl 13.23µm ±0.43 SEM, p<0.0001) and basal laminar area (SFD 6µm2 ± 0.446 SEM, ctrl 14µm2 ±0.65 SEM, p<0.0001). Striated sub RPE deposits were observed, consistent with long-spacing collagen. A significantly higher number of focal collagen deposits were seen per cell in ctrl-RPE compared to SFD-RPE (SFD 1.444 ±0.44 SEM, ctrl 3.286 ± 0.52 SEM, p<0.05). The number of melanosomes per cell was also significantly higher in ctrl-RPE compared to SFD-RPE (SFD 40.2 ±2.34 SEM, ctrl 57.54 ± 3.74 SEM, p<0.001). However, there was no difference in their basal/apical distribution. SFD-RPE cells showed significantly lower average TEER over 90 days in culture compared to ctrl-RPE (SFD1 161.1 ± 15.9 SEM, ctrl 499.4 ± 49.79 SEM, p<0.001). The enzyme assay showed TIMP3 S204C mutation does not significantly affect the ability of TIMP3 to inhibit collagenase.

Conclusions : The S204C TIMP3 mutation reduces the barrier integrity of RPE cells and results in key morphological alterations to the RPE, including cell height, not previously described. However, our findings indicate that the S204C mutation does not affect TIMP3’s ability to inhibit MMP-9 activity.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×